Members |
targetComponentId |
Buprenorphine hydrochloride + naloxone hydrochloride |
Product containing buprenorphine and naloxone (medicinal product) |
buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
bupropionhydroklorid 100 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 100 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 200 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 200 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 300 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 300 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 50 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydroklorid 50 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
Burkholderia |
Genus Burkholderia (organism) |
Burkholderia cocovenenans |
Burkholderia gladioli |
Burkholderia vandii |
Burkholderia plantarii |
Burkitts lymfom i lymfknutor i axill och arm |
Burkitt lymphoma of lymph nodes of upper limb (disorder) |
Burkitts lymfom i lymfknutor i inguinalregion och ben |
Burkitt lymphoma of lymph nodes of lower limb (disorder) |
Burkitts tumör, extranodal och/eller organlokaliserad |
Burkitt's lymphoma (clinical) |
Burkitts lymfom i lymfknutor i axill och/eller arm |
Burkitt lymphoma of lymph nodes of upper limb (disorder) |
Burkitts lymfom i lymfknutor i inguinalregion och/eller ben |
Burkitt lymphoma of lymph nodes of lower limb (disorder) |
brännskada som engagerar 10-14 procent av kroppsytan, varvid 10-14 procent av kroppsytan är fullhudsbrännskadad |
Burn involving 10-19 percent of body surface, with 10-14 percent of body surface with full thickness burn (disorder) |
brännskada som engagerar 15-19 procent av kroppsytan, varvid 10-19 procent av kroppsytan är fullhudsbrännskadad |
Burn involving 10-19 percent of body surface, with 15-19 percent of body surface with full thickness burn (disorder) |
Burn of larynx, trachea AND/OR lung |
Burn |
Burn of other internal organ, NEC |
Burn of internal organ |
Burn to cornea - erythema |
Corneal burn |
Burn to cornea - erythema |
Corneal burn |
buserelin 150 mikrogram, sprej |
Buserelin only product |
Buspirone hydrochloride 5mg tablet |
Buspirone hydrochloride 5 mg oral tablet |
Buspirone hydrochlorine |
Buspirone hydrochloride (substance) |
butabarbitalnatrium 30 mg/5 ml, elixir |
Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull |
Butorphanol tartrate 1 mg/mL solution for injection |
butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull |
Butorphanol only product in parenteral dose form |
icke kärlsäkrad skinklambå |
Random pattern flap |
toxisk effekt av knappbatteri |
Toxic effect of sulfuric acid |
butylnitrat, icke läkemedel |
Butyl nitrate |
antipsykotiskt medel innehållande butyrofenonderivat |
Butyrophenone derivative |
Butyrophenone poisoning NOS |
Poisoning by butyrophenone-based tranquilizer |
Bypass of organ NOC |
Construction of shunt |
behandling med Byrds respirator |
Respiratory therapy |
C/O - specified symptom findings |
Finding reported by subject or history provider (finding) |
C1-esterashämmare 500 enheter, pulver till injektionsvätska, lösning, injektionsflaska 8 ml |
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
CDC Corynebacterium group G-1 |
Corynebacterium accolens |
CDC group DF-2 |
Capnocytophaga canimorsus |
CDE genotype |
CDE haplotype (finding) |
CDe genotype |
CDe haplotype (finding) |
CTV3 ROOT |
SNOMED CT Concept |
kål, livsmedel |
Cabbage (substance) |
Cabergoline [parkinsons] |
Product containing cabergoline (medicinal product) |
Caesarean delivery - delivered |
Deliveries by caesarean |
Caffeine and sodium benzoate injection |
Product containing caffeine and sodium benzoate (medicinal product) |
koffeininnehållande substans, icke läkemedel |
Caffeine |
café-au-lait-fläckar och ringkromosom 11 |
Ring chromosome 11 syndrome |
kalcipotrien 0,005 %/betametason 0,064 %, suspension för lokalt bruk |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
kalcitonin från lax 100 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
laxkalcitonin 200 IE/ml, sprej |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
Calcitonin, salmon 200unt/mL injection |
Salmon calcitonin 200 unit/mL solution for injection |
kalcitonin från lax 200 enheter/ml, injektionsvätska, lösning, flaska 2 ml |
Salmon calcitonin 200 unit/mL solution for injection |
Calcium analyte |
Calcium |
kalciumbaserat antacidum |
Calcium compound |
kalciumkarbonat 1,25 g + kolekalciferol 11 mikrogram, dospåse med granulat |
Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution |
kalciumklorid 10 %, injektionsvätska, lösning, förfylld spruta 10 ml |
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 0,3 ml |
Hydroxyapatite only product in parenteral dose form |
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 1,3 ml |
Hydroxyapatite only product in parenteral dose form |
kalciumfosfat 3 100 mg + cholekalciferol 20 mikrogram per dospåse, pulver till oral suspension |
Calcium phosphate and colecalciferol only product |
Calculus - composition |
Calculus chemical composition - finding |
Calculus exam. general |
Calculus examination |
Calculus examination NOS |
Calculus examination |
Calculus examination NOS |
Calculus examination |
allmän undersökning av sten |
Calculus examination |
Calculus gen. exam. NOS |
Calculus examination |
Calculus general examination NOS |
Calculus examination |
kalfaktant, intratraekal suspension, flaska 6 ml |
Product containing only calfactant (medicinal product) |
Calicivirus group |
Family Caliciviridae (organism) |
Calliphora erythrocephala |
Calliphora vicina |
Callitrogae |
Genus Cochliomyia (organism) |
Caloric intake, function (observable entity) |
Energy intake (observable entity) |
Caloscypha fulgens |
Caloscypha fulgens (organism) |
Calymmatobacterium granulomatis |
Klebsiella granulomatis (organism) |
biverkning av kamouflerande preparat |
Adverse reaction (disorder) |
Campylobacter cinaedi |
Helicobacter cinaedi |
Campylobacter fennelliae |
Helicobacter fennelliae |
Campylobacter laridis |
Campylobacter lari |
Campylobacter laridis rRNA |
Campylobacter lari rRNA |
Campylobacter laridis rRNA assay |
Campylobacter lari rRNA assay |
Campylobacter nitrofigilis |
Arcobacter nitrofigilis (organism) |
kanakinumab 150 mg, pulver till injektionsvätska, lösning |
Canakinumab only product |
cancervårdplan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
genomgång av cancerbehandling |
Cancer care review (procedure) |
utförd screening för livmoderhalscancer |
Screening for malignant neoplasm of cervix done (situation) |
Candida famata |
Debaryomyces hansenii |
Candida famata |
Debaryomyces hansenii |
Candida guilliermondii, varietet guilliermondii |
Meyerozyma guilliermondii (organism) |
Candida humicola |
Vanrija humicola (organism) |
Candida krusei var. vanlaeriana |
Pichia membranifaciens (organism) |
Candida lipolytica |
Yarrowia lipolytica |
Candida pseudotropicalis |
Kluyveromyces marxianus |
Candidiasis of other specified sites |
Candidiasis |
Candidiasis of other urogenital sites |
Candidiasis of urogenital site |
Canine cortical hyperostosis |
Disorder of bone (disorder) |
Canis familiaris |
Canis lupus subspecies familiaris (organism) |